VarCov Co’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
VarCov Co's IBRX Position: Q3 2026 in Review
VarCov Co increased its ImmunityBio (IBRX) stake by 215% in Q3 2026, buying an estimated $239K and bringing the position to 43,830 shares worth $414K. The position accounts for 0.2% of the portfolio, ranked #182.
VarCov Co first reported a position in IBRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $524K in Q4 2025. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- VarCov Co held 43,830 shares of ImmunityBio worth $414K as of Q3 2026.
- VarCov Co bought 29,924 ImmunityBio shares in Q3 2026, an estimated $239K.
- ImmunityBio made up 0.2% of VarCov Co's portfolio in Q3 2026, its #182 holding.
- VarCov Co first reported a position in ImmunityBio in Q4 2025 and has held it in 3 quarters since.
- VarCov Co's ImmunityBio position peaked at $524K in Q4 2025.
- 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.